Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nutrasal is a specialized healthcare company focused on the development and distribution of pharmaceutical-grade purified phospholipids and advanced liposomal delivery systems. Established in 1982, the company has become a primary source for high-purity phosphatidylcholine, marketed under the flagship brand name PhosChol, which is used globally for liver, cardiovascular, and neurological support. Nutrasal's core competency lies in its proprietary liposomal encapsulation technology, which significantly improves the bioavailability of nutritional and therapeutic actives. The company serves a diverse clientele, including healthcare professionals, researchers, and health-conscious consumers. Nutrasal maintains rigorous quality control standards, ensuring their products meet the high demands of clinical and therapeutic applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nutrasal.